Automated & scalable closed-system platform for cell isolation and activation

Cell & Gene Therapy Insights 2022; 8(10), 1283

DOI: 10.18609/cgti.2022.188

Published: 3 November 2022
Poster
Hany Meås

The cell therapy field is experiencing rapid growth with several recent regulatory approvals and further therapies in clinical testing. The Gibco™ CTS™ DynaCellect™ Magnetic Separation System and single-use kits have been designed for scalable and robust cell processing with the CTS Dynabeads™ platform. Using the Gibco CTS DynaCellect Cell Isolation Kit with CTS Dynabeads, >85% isolation efficiency of target cells with >95% purity is consistently achieved with no effect on cell viability.